ImmunityBio, Inc.IBRXNASDAQ
Loading
Operating Income Growth AcceleratingAccelerating
Percentile Rank83
Studio
Year-over-Year Change

Year-over-year operating income growth rate

Latest
25.61%
↑ 263% vs avg
Percentile
P83
Within normal range
Streak
5 yr
Consecutive growthAccelerating
Average
-15.75%
Historical baseline
PeriodValue
202525.61%
20244.99%
2023-3.12%
2022-6.36%
2021-49.53%
2020-230.13%
201932.00%
20180.74%
201720.39%
201647.88%